|
1
|
Cardiac-resynchronization therapy for the prevention of heart-failure events.
|
N Engl J Med
|
2009
|
12.44
|
|
2
|
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons.
|
Circulation
|
2008
|
8.94
|
|
3
|
Reduction in inappropriate therapy and mortality through ICD programming.
|
N Engl J Med
|
2012
|
8.84
|
|
4
|
Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.
|
N Engl J Med
|
2004
|
7.12
|
|
5
|
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons.
|
J Am Coll Cardiol
|
2008
|
6.78
|
|
6
|
2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.
|
Circulation
|
2011
|
4.48
|
|
7
|
Percutaneous Implantation of an Entirely Intracardiac Leadless Pacemaker.
|
N Engl J Med
|
2015
|
4.26
|
|
8
|
Survival with cardiac-resynchronization therapy in mild heart failure.
|
N Engl J Med
|
2014
|
3.80
|
|
9
|
Ventricular pacing or dual-chamber pacing for sinus-node dysfunction.
|
N Engl J Med
|
2002
|
3.35
|
|
10
|
Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
|
JAMA
|
2007
|
3.32
|
|
11
|
2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.
|
J Am Coll Cardiol
|
2012
|
3.25
|
|
12
|
Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association.
|
Circulation
|
2010
|
3.17
|
|
13
|
Arrhythmogenic right ventricular cardiomyopathy/dysplasia clinical presentation and diagnostic evaluation: results from the North American Multidisciplinary Study.
|
Heart Rhythm
|
2009
|
2.82
|
|
14
|
ACC/AHA/HRS 2008 guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: executive summary.
|
Heart Rhythm
|
2008
|
2.75
|
|
15
|
Adverse cardiovascular events temporally associated with ma huang, an herbal source of ephedrine.
|
Mayo Clin Proc
|
2002
|
2.67
|
|
16
|
Commotio cordis.
|
N Engl J Med
|
2010
|
2.67
|
|
17
|
Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia.
|
Circulation
|
2003
|
2.56
|
|
18
|
Exercise and acute cardiovascular events placing the risks into perspective: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism and the Council on Clinical Cardiology.
|
Circulation
|
2007
|
2.49
|
|
19
|
2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.
|
J Am Coll Cardiol
|
2011
|
2.48
|
|
20
|
2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
|
Circulation
|
2010
|
2.48
|
|
21
|
2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.
|
Circulation
|
2012
|
2.39
|
|
22
|
Recommendations for interpretation of 12-lead electrocardiogram in the athlete.
|
Eur Heart J
|
2009
|
2.37
|
|
23
|
2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
|
J Am Coll Cardiol
|
2012
|
2.23
|
|
24
|
Acquired long QT syndrome from stress cardiomyopathy is associated with ventricular arrhythmias and torsades de pointes.
|
Heart Rhythm
|
2010
|
2.15
|
|
25
|
Executive summary: HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes.
|
Europace
|
2013
|
1.97
|
|
26
|
2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
|
Heart Rhythm
|
2010
|
1.89
|
|
27
|
2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
|
J Am Coll Cardiol
|
2010
|
1.87
|
|
28
|
Clinical profile and spectrum of commotio cordis.
|
JAMA
|
2002
|
1.86
|
|
29
|
Syncope and risk of sudden death in hypertrophic cardiomyopathy.
|
Circulation
|
2009
|
1.85
|
|
30
|
High incidence of pacemaker syndrome in patients with sinus node dysfunction treated with ventricular-based pacing in the Mode Selection Trial (MOST).
|
J Am Coll Cardiol
|
2004
|
1.83
|
|
31
|
Efficacy of antiarrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: a report from the North American ARVC Registry.
|
J Am Coll Cardiol
|
2009
|
1.83
|
|
32
|
Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases.
|
Circulation
|
2004
|
1.82
|
|
33
|
Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
|
J Am Coll Cardiol
|
2013
|
1.79
|
|
34
|
2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on Dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.
|
Circulation
|
2011
|
1.73
|
|
35
|
ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities.
|
Heart Rhythm
|
2008
|
1.72
|
|
36
|
Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy.
|
J Am Coll Cardiol
|
2013
|
1.65
|
|
37
|
ACC/AHA classification of care metrics: performance measures and quality metrics: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.
|
J Am Coll Cardiol
|
2008
|
1.60
|
|
38
|
Preserved heart rate variability identifies low-risk patients with nonischemic dilated cardiomyopathy: results from the DEFINITE trial.
|
Heart Rhythm
|
2006
|
1.55
|
|
39
|
Preventing sudden cardiac death: can we afford the benefit?
|
Ann Intern Med
|
2005
|
1.55
|
|
40
|
Incidence and significance of pacemaker and implantable cardioverter-defibrillator lead masses discovered during transesophageal echocardiography.
|
Pacing Clin Electrophysiol
|
2011
|
1.54
|
|
41
|
AACVPR/ACC/AHA 2007 performance measures on cardiac rehabilitation for referral to and delivery of cardiac rehabilitation/secondary prevention services endorsed by the American College of Chest Physicians, American College of Sports Medicine, American Physical Therapy Association, Canadian Association of Cardiac Rehabilitation, European Association for Cardiovascular Prevention and Rehabilitation, Inter-American Heart Foundation, National Association of Clinical Nurse Specialists, Preventive Cardiovascular Nurses Association, and the Society of Thoracic Surgeons.
|
J Am Coll Cardiol
|
2007
|
1.51
|
|
42
|
Circadian patterns in the occurrence of malignant ventricular tachyarrhythmias triggering defibrillator interventions in patients with hypertrophic cardiomyopathy.
|
Heart Rhythm
|
2009
|
1.51
|
|
43
|
Clinical decisions. Cardiac screening before participation in sports.
|
N Engl J Med
|
2013
|
1.51
|
|
44
|
One conversion of ventricular fibrillation is adequate for implantable cardioverter-defibrillator implant: an analysis from the Low Energy Safety Study (LESS).
|
Heart Rhythm
|
2005
|
1.50
|
|
45
|
ACC/AHA/Physician Consortium 2008 clinical performance measures for adults with nonvalvular atrial fibrillation or atrial flutter: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and the Physician Consortium for Performance Improvement (Writing Committee to Develop Clinical Performance Measures for Atrial Fibrillation): developed in collaboration with the Heart Rhythm Society.
|
Circulation
|
2008
|
1.48
|
|
46
|
Death in a young athlete due to commotio cordis despite prompt external defibrillation.
|
Heart Rhythm
|
2005
|
1.48
|
|
47
|
Time-dependence of appropriate implantable defibrillator therapy in patients with ischemic cardiomyopathy.
|
J Cardiovasc Electrophysiol
|
2008
|
1.47
|
|
48
|
Enalapril treatment and hospitalization with atrial tachyarrhythmias in patients with left ventricular dysfunction.
|
Am Heart J
|
2004
|
1.47
|
|
49
|
2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management.
|
Europace
|
2012
|
1.46
|
|
50
|
The automated external defibrillator: clinical benefits and legal liability.
|
JAMA
|
2006
|
1.46
|
|
51
|
2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
|
J Thorac Cardiovasc Surg
|
2012
|
1.45
|
|
52
|
Increasing survival rate from commotio cordis.
|
Heart Rhythm
|
2012
|
1.45
|
|
53
|
Variant angina associated with bitter orange in a dietary supplement.
|
Mayo Clin Proc
|
2006
|
1.40
|
|
54
|
Equivalent arrhythmic risk in patients recently diagnosed with dilated cardiomyopathy compared with patients diagnosed for 9 months or more.
|
Heart Rhythm
|
2006
|
1.40
|
|
55
|
Inducible ventricular flutter and fibrillation predict for arrhythmia occurrence in coronary artery disease patients presenting with syncope of unknown origin.
|
J Cardiovasc Electrophysiol
|
2002
|
1.38
|
|
56
|
2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. [corrected].
|
Circulation
|
2012
|
1.37
|
|
57
|
Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines.
|
Circulation
|
2013
|
1.31
|
|
58
|
Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia.
|
Circulation
|
2010
|
1.31
|
|
59
|
Task Force 7: arrhythmias.
|
J Am Coll Cardiol
|
2005
|
1.30
|
|
60
|
2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
|
J Am Coll Cardiol
|
2015
|
1.26
|
|
61
|
Clinical evaluation of cardiovascular devices: principles, problems, and proposals for European regulatory reform. Report of a policy conference of the European Society of Cardiology.
|
Eur Heart J
|
2011
|
1.25
|
|
62
|
Upper and lower limits of vulnerability to sudden arrhythmic death with chest-wall impact (commotio cordis).
|
J Am Coll Cardiol
|
2003
|
1.24
|
|
63
|
Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy.
|
Circulation
|
2003
|
1.20
|
|
64
|
ACC/AHA/Physician Consortium 2008 Clinical Performance Measures for Adults with Nonvalvular Atrial Fibrillation or Atrial Flutter: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and the Physician Consortium for Performance Improvement (Writing Committee to Develop Clinical Performance Measures for Atrial Fibrillation) Developed in Collaboration with the Heart Rhythm Society.
|
J Am Coll Cardiol
|
2008
|
1.17
|
|
65
|
2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.
|
Europace
|
2015
|
1.13
|
|
66
|
Recommendations from the Heart Rhythm Society Task Force on Lead Performance Policies and Guidelines: developed in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA).
|
Heart Rhythm
|
2009
|
1.12
|
|
67
|
2012 ACCF/AHA/HRS Focused Update of the 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
|
Heart Rhythm
|
2012
|
1.11
|
|
68
|
Interpretation of the electrocardiogram of young athletes.
|
Circulation
|
2011
|
1.10
|
|
69
|
Durability of repaired sensing leads equivalent to that of new leads in implantable cardioverter defibrillator patients with sensing abnormalities.
|
Pacing Clin Electrophysiol
|
2003
|
1.08
|
|
70
|
Association of prolonged QRS duration with ventricular tachyarrhythmias and sudden cardiac death in the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II).
|
Heart Rhythm
|
2008
|
1.05
|
|
71
|
Ablation after ICD implantation--bridging the gap between promise and practice.
|
N Engl J Med
|
2007
|
1.05
|
|
72
|
Safety of sports for athletes with implantable cardioverter-defibrillators: results of a prospective, multinational registry.
|
Circulation
|
2013
|
1.04
|
|
73
|
Heart Rhythm Society Policy Statement Update: Recommendations on the Role of Industry Employed Allied Professionals (IEAPs).
|
Heart Rhythm
|
2008
|
1.04
|
|
74
|
Arrhythmogenic right ventricular cardiomyopathy/dysplasia: risk stratification and therapy.
|
Prog Cardiovasc Dis
|
2007
|
1.04
|
|
75
|
Commotio cordis--sudden cardiac death with chest wall impact.
|
J Cardiovasc Electrophysiol
|
2007
|
1.02
|
|
76
|
ACC/AHA classification of care metrics: performance measures and quality metrics: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.
|
Circulation
|
2008
|
0.99
|
|
77
|
Cardiovascular toxicities of performance-enhancing substances in sports.
|
Mayo Clin Proc
|
2005
|
0.98
|
|
78
|
Sex differences in outcome after implantable cardioverter defibrillator implantation in nonischemic cardiomyopathy.
|
Am Heart J
|
2008
|
0.98
|
|
79
|
Sudden cardiac death in athletes.
|
Curr Cardiol Rep
|
2006
|
0.98
|
|
80
|
American Heart Association atrial fibrillation research summit: a conference report from the American Heart Association.
|
Circulation
|
2011
|
0.97
|
|
81
|
Timing cycles for biventricular pacing.
|
Pacing Clin Electrophysiol
|
2002
|
0.96
|
|
82
|
Cell membrane stretch and chest blow-induced ventricular fibrillation: commotio cordis.
|
J Cardiovasc Electrophysiol
|
2008
|
0.96
|
|
83
|
Failure of commercially available chest wall protectors to prevent sudden cardiac death induced by chest wall blows in an experimental model of commotio cordis.
|
Pediatrics
|
2006
|
0.96
|
|
84
|
Effectiveness of automated external defibrillators in high schools in greater Boston.
|
Am J Cardiol
|
2005
|
0.95
|
|
85
|
Risk of arrhythmic and nonarrhythmic death in patients with heart failure and chronic kidney disease.
|
Am Heart J
|
2011
|
0.95
|
|
86
|
Evaluation of chest barriers for protection against sudden death due to commotio cordis.
|
Am J Cardiol
|
2007
|
0.95
|
|
87
|
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 9: Arrhythmias and Conduction Defects: A Scientific Statement From the American Heart Association and American College of Cardiology.
|
J Am Coll Cardiol
|
2015
|
0.94
|
|
88
|
2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: Executive summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
|
Heart Rhythm
|
2015
|
0.94
|
|
89
|
Role of streptomycin-sensitive stretch-activated channel in chest wall impact induced sudden death (commotio cordis).
|
J Cardiovasc Electrophysiol
|
2005
|
0.92
|
|
90
|
Commotio cordis and the epidemiology of sudden death in competitive lacrosse.
|
Pediatrics
|
2009
|
0.92
|
|
91
|
Task Force 10: automated external defibrillators.
|
J Am Coll Cardiol
|
2005
|
0.91
|
|
92
|
A summary of the update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association.
|
J Am Dent Assoc
|
2011
|
0.91
|
|
93
|
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology.
|
J Am Coll Cardiol
|
2015
|
0.91
|
|
94
|
Relation of 12-lead electrocardiogram patterns to implanted defibrillator-terminated ventricular tachyarrhythmias in hypertrophic cardiomyopathy.
|
Am J Cardiol
|
2009
|
0.90
|
|
95
|
Short QT syndrome review.
|
J Interv Card Electrophysiol
|
2008
|
0.90
|
|
96
|
Sudden cardiac death in the athlete: bridging the gaps between evidence, policy, and practice.
|
Circulation
|
2012
|
0.89
|
|
97
|
Echocardiographic evidence of left atrial abnormality in young patients with lone paroxysmal atrial fibrillation.
|
Am J Cardiol
|
2004
|
0.88
|
|
98
|
The short QT syndrome.
|
J Interv Card Electrophysiol
|
2011
|
0.88
|
|
99
|
Reduced risk of sudden death from chest wall blows (commotio cordis) with safety baseballs.
|
Pediatrics
|
2002
|
0.88
|
|
100
|
2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran). A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
|
Heart Rhythm
|
2011
|
0.87
|
|
101
|
Task Force 11: commotio cordis.
|
J Am Coll Cardiol
|
2005
|
0.87
|
|
102
|
Frequent ICD shocks due to double sensing in patients with bi-ventricular implantable cardioverter defibrillators.
|
J Interv Card Electrophysiol
|
2003
|
0.87
|
|
103
|
ECG screening for athletes: letting evidence and reason advance the debate.
|
Heart Rhythm
|
2010
|
0.85
|
|
104
|
Historical observation on commotio cordis.
|
Heart Rhythm
|
2006
|
0.85
|
|
105
|
ACC/AHA 2008 statement on performance measurement and reperfusion therapy: a report of the ACC/AHA Task Force on Performance Measures (Work Group to address the challenges of performance measurement and reperfusion therapy).
|
Circulation
|
2008
|
0.85
|
|
106
|
Protecting our children from the consequences of chest blows on the playing field: a time for science over marketing.
|
Pediatrics
|
2008
|
0.85
|
|
107
|
Effects of estrogen on cardiac electrophysiology in female mice.
|
J Cardiovasc Electrophysiol
|
2002
|
0.84
|
|
108
|
New concepts in pacemaker syndrome.
|
Indian Pacing Electrophysiol J
|
2004
|
0.84
|
|
109
|
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 13: Commotio Cordis: A Scientific Statement From the American Heart Association and American College of Cardiology.
|
Circulation
|
2015
|
0.84
|
|
110
|
Automated external defibrillator arrhythmia detection in a model of cardiac arrest due to commotio cordis.
|
J Cardiovasc Electrophysiol
|
2003
|
0.84
|
|
111
|
Sudden cardiac death in young athletes and nonathletes.
|
Curr Opin Crit Care
|
2011
|
0.83
|
|
112
|
Cryoablation of the pulmonary veins using a novel balloon catheter.
|
J Interv Card Electrophysiol
|
2006
|
0.83
|
|
113
|
American Heart Association Response to the 2015 Institute of Medicine Report on Strategies to Improve Cardiac Arrest Survival.
|
Circulation
|
2015
|
0.83
|
|
114
|
High risk of ventricular arrhythmias in patients with nonischemic dilated cardiomyopathy presenting with syncope.
|
Am J Cardiol
|
2006
|
0.82
|
|
115
|
Importance of the autonomic nervous system in an experimental model of commotio cordis.
|
Med Sci Monit
|
2006
|
0.82
|
|
116
|
Prevention of sudden cardiac death in patients with chronic kidney disease: risk and benefits of the implantable cardioverter defibrillator.
|
J Interv Card Electrophysiol
|
2012
|
0.82
|
|
117
|
How to manage athletes with syncope.
|
Cardiol Clin
|
2007
|
0.81
|
|
118
|
Atrioventricular nodal reverse facilitation in connexin40-deficient mice.
|
Heart Rhythm
|
2005
|
0.81
|
|
119
|
Prevalence of sensing abnormalities in dual chamber implantable cardioverter defibrillators.
|
Ann Noninvasive Electrocardiol
|
2003
|
0.81
|
|
120
|
2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
|
Heart Rhythm
|
2015
|
0.81
|
|
121
|
The Relationship between Obstructive Sleep Apnea and Atrial Fibrillation: A Complex Interplay.
|
Pulm Med
|
2013
|
0.80
|
|
122
|
Comparison of survival and other complications after heart transplantation in patients taking amiodarone before surgery versus those not taking amiodarone.
|
Am J Cardiol
|
2004
|
0.80
|
|
123
|
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 9: Arrhythmias and Conduction Defects: A Scientific Statement From the American Heart Association and American College of Cardiology.
|
Circulation
|
2015
|
0.80
|
|
124
|
Addendum to "Personal and Public Safety Issues Related to Arrhythmias That May Affect Consciousness: Implications for Regulation and Physician Recommendations. A medical/scientific statement from the American Heart Association and the North American Society of Pacing and Electrophysiology". Public safety issues in patients with implantable defibrillators. A Scientific statement from the American Heart Association and the Heart Rhythm Society.
|
Heart Rhythm
|
2007
|
0.80
|
|
125
|
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology.
|
Circulation
|
2015
|
0.79
|
|
126
|
Surgery for atrial fibrillation: current state-of-the-art.
|
J Interv Card Electrophysiol
|
2007
|
0.79
|
|
127
|
Syncope in the patient with nonischemic dilated cardiomyopathy.
|
Pacing Clin Electrophysiol
|
2004
|
0.79
|
|
128
|
Predictors and clinical impact of atrial fibrillation after pacemaker implantation in elderly patients treated with dual chamber versus ventricular pacing.
|
Pacing Clin Electrophysiol
|
2003
|
0.79
|
|
129
|
Athletes and arrhythmias.
|
J Cardiovasc Electrophysiol
|
2010
|
0.79
|
|
130
|
Differential effects of statins (pravastatin or simvastatin) on ventricular ectopic complexes: Galpha(i2), a possible molecular marker for ventricular irritability.
|
Am J Cardiol
|
2010
|
0.79
|
|
131
|
Computerized interpretation of ECGs: supplement not a substitute.
|
Circ Arrhythm Electrophysiol
|
2013
|
0.78
|
|
132
|
Catheter ablation of atrial fibrillation: is the burn worth the buck?
|
J Cardiovasc Electrophysiol
|
2007
|
0.78
|
|
133
|
Primary prevention of sudden cardiac death: a rational approach to the use of the implantable cardioverter defibrillator.
|
J Interv Card Electrophysiol
|
2005
|
0.78
|
|
134
|
Multicenter automatic defibrillator implantation trial: reduce inappropriate therapy (MADIT-RIT): background, rationale, and clinical protocol.
|
Ann Noninvasive Electrocardiol
|
2012
|
0.77
|
|
135
|
Mechanically induced ventricular fibrillation (commotio cordis).
|
Heart Rhythm
|
2006
|
0.77
|
|
136
|
Sudden cardiac arrest from primary electrical diseases: provoking concealed arrhythmogenic syndromes.
|
Circulation
|
2005
|
0.77
|
|
137
|
Global epidemiology and demographics of commotio cordis.
|
Heart Rhythm
|
2011
|
0.77
|
|
138
|
Herbal medicine: beneficial effects, side effects, and promising new research in the treatment of arrhythmias.
|
Curr Cardiol Rep
|
2003
|
0.77
|
|
139
|
Focusing on the future: a new Heart Rhythm Society strategic plan.
|
Heart Rhythm
|
2009
|
0.77
|
|
140
|
Cardiac arrhythmias in the athlete: the evolving role of electrophysiology.
|
Curr Sports Med Rep
|
2002
|
0.77
|
|
141
|
2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
|
J Am Coll Cardiol
|
2015
|
0.77
|
|
142
|
Addendum to "Personal and public safety issues related to arrhythmias that may affect consciousness: implications for regulation and physician recommendations: a medical/scientific statement from the American Heart Association and the North American Society of Pacing and Electrophysiology": public safety issues in patients with implantable defibrillators: a scientific statement from the American Heart Association and the Heart Rhythm Society.
|
Circulation
|
2007
|
0.77
|
|
143
|
Prediction and prevention of sudden death in young populations: the role of ECG screening.
|
J Interv Card Electrophysiol
|
2012
|
0.77
|
|
144
|
Ventricular tachycardia/fibrillation early after defibrillator implantation in patients with hypertrophic cardiomyopathy is explained by a high-risk subgroup of patients.
|
Heart Rhythm
|
2012
|
0.76
|
|
145
|
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 12: Emergency Action Plans, Resuscitation, Cardiopulmonary Resuscitation, and Automated External Defibrillators: A Scientific Statement From the American Heart Association and American College of Cardiology.
|
J Am Coll Cardiol
|
2015
|
0.76
|
|
146
|
Precordial thump for cardiac arrest is effective for asystole but not for ventricular fibrillation.
|
Heart Rhythm
|
2009
|
0.76
|
|
147
|
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 13: Commotio Cordis: A Scientific Statement From the American Heart Association and American College of Cardiology.
|
J Am Coll Cardiol
|
2015
|
0.76
|
|
148
|
Early descriptions of sudden cardiac death due to commotio cordis occurring in baseball.
|
Heart Rhythm
|
2010
|
0.76
|
|
149
|
Prediction and prevention of sudden cardiac arrest: lessons learned in schools.
|
Circulation
|
2007
|
0.75
|
|
150
|
Cardiac resynchronization therapy: extending current responses to phrenic nerve stimulation.
|
J Cardiovasc Electrophysiol
|
2014
|
0.75
|
|
151
|
Automated external defibrillators--device reliability and clinical benefits.
|
JAMA
|
2006
|
0.75
|
|
152
|
Cardiac safety of electrical stun guns: letting science and reason advance the debate.
|
Pacing Clin Electrophysiol
|
2008
|
0.75
|
|
153
|
Catheter cryoablation of supraventricular tachycardia: Quo vadis?
|
Heart Rhythm
|
2004
|
0.75
|
|
154
|
Reply: Effectiveness of antitachycardia pacing for recurrent ventricular tachycardia in ARVC.
|
J Am Coll Cardiol
|
2014
|
0.75
|
|
155
|
Atrial tachyarrhythmias detected by automatic mode switching: quo vadis?
|
J Cardiovasc Electrophysiol
|
2004
|
0.75
|
|
156
|
Anticoagulation control in atrial fibrillation: optimizing risks and benefits.
|
Circ Cardiovasc Qual Outcomes
|
2008
|
0.75
|
|
157
|
Guidelines for cardiac arrhythmias: practice makes progress.
|
Circ Arrhythm Electrophysiol
|
2011
|
0.75
|
|
158
|
Implantable cardioverter-defibrillator product reliability: recalling lessons from a tragic case.
|
Heart Rhythm
|
2005
|
0.75
|
|
159
|
Abstracts to manuscripts: advancing the HRS research mission.
|
Heart Rhythm
|
2009
|
0.75
|
|
160
|
The heart of an athlete: black, white, and shades of grey with no gold standard.
|
Circulation
|
2013
|
0.75
|
|
161
|
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 11: Drugs and Performance-Enhancing Substances: A Scientific Statement From the American Heart Association and American College of Cardiology.
|
Circulation
|
2015
|
0.75
|
|
162
|
Defibrillation testing: should the paradigm shift?
|
J Am Coll Cardiol
|
2012
|
0.75
|
|
163
|
The challenge of predicting and preventing sudden cardiac death immediately after myocardial infarction.
|
Circulation
|
2009
|
0.75
|
|
164
|
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 12: Emergency Action Plans, Resuscitation, Cardiopulmonary Resuscitation, and Automated External Defibrillators: A Scientific Statement From the American Heart Association and American College of Cardiology.
|
Circulation
|
2015
|
0.75
|
|
165
|
To the editor: response---Irreplaceable antiarrhythmic medications are disappearing: the case of quinidine.
|
Heart Rhythm
|
2010
|
0.75
|
|
166
|
Neuropsychological effects of atrial fibrillation catheter ablation: a manifestation of the occult?
|
Heart Rhythm
|
2010
|
0.75
|
|
167
|
Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 11: Drugs and Performance-Enhancing Substances: A Scientific Statement From the American Heart Association and American College of Cardiology.
|
J Am Coll Cardiol
|
2015
|
0.75
|
|
168
|
Atrial fibrillation detected by automatic mode switching: from fool's gold toward a gold standard.
|
J Cardiovasc Electrophysiol
|
2002
|
0.75
|
|
169
|
Screening for sudden death in the athlete.
|
Cardiovasc Pathol
|
2010
|
0.75
|
|
170
|
Cardiology patient pages. Supraventricular tachycardia.
|
Circulation
|
2002
|
0.75
|
|
171
|
Agreement between ICU clinicians and electrophysiology cardiologists on the decision to initiate a QTc-interval prolonging medication in critically ill patients with potential risk factors for torsade de pointes: a comparative, case-based evaluation.
|
Pharmacotherapy
|
2013
|
0.75
|
|
172
|
Treatment of athletes with cardiac disease or arrhythmias.
|
Curr Treat Options Cardiovasc Med
|
2006
|
0.75
|
|
173
|
Extraction of buried P waves from printed electrocardiograms.
|
Ann Noninvasive Electrocardiol
|
2005
|
0.75
|
|
174
|
Latency of ECG displays of hospital telemetry systems: a science advisory from the American Heart Association.
|
Circulation
|
2012
|
0.75
|
|
175
|
Clinical results with catheter ablation: AV junction, atrial fibrillation and ventricular tachycardia.
|
J Interv Card Electrophysiol
|
2003
|
0.75
|
|
176
|
Emerging therapies for atrial fibrillation: is the paradigm shifting?
|
J Interv Card Electrophysiol
|
2010
|
0.75
|
|
177
|
Task Force 9: drugs and performance-enhancing substances.
|
J Am Coll Cardiol
|
2005
|
0.75
|
|
178
|
Inappropriate shock and pacing?
|
J Cardiovasc Electrophysiol
|
2003
|
0.75
|
|
179
|
Reply: Diabetic Cardiomyopathy Patients Are More Complex and Require a Nuanced Approach.
|
JACC Clin Electrophysiol
|
2020
|
0.75
|
|
180
|
New paradigms in the prevention of sudden cardiac arrest and heart failure treatment.
|
Curr Cardiol Rep
|
2011
|
0.75
|
|
181
|
Advances in implantable cardioverter defibrillators.
|
Curr Opin Cardiol
|
2002
|
0.75
|
|
182
|
2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.
|
J Am Coll Cardiol
|
2016
|
0.75
|
|
183
|
A narrow and two wide QRS complex tachycardias: what are the mechanisms?
|
Pacing Clin Electrophysiol
|
2002
|
0.75
|